Singlepoint Healthcare

Based in the US, Singlepoint Healthcare Inc. offers specialized healthcare services focused on managing chronic inflammatory diseases, with a comprehensive approach to patient care. Singlepoint Healthcare is dedicated to managing chronic inflammatory diseases through a specialized care model. Founded in 2025 in Wood Dale, US, the company has conducted 1 deal to date.

DFW Capital Partners acquired Singlepoint Healthcare; financial terms were not disclosed. Singlepoint Healthcare specializes in providing a comprehensive care model focused on the management of chronic inflammatory diseases, particularly within the fields of neurology, rheumatology, and immunology. The company's core offerings include specialized diagnostic services, infusion therapies, physical therapy, nutritional counseling, and integrated support services aimed at addressing complex inflammatory and autoimmune conditions. They serve a diverse clientele, including individuals diagnosed with multiple sclerosis (MS), neuromyelitis optica (NMO), chronic migraines, and MOG antibody disease (MOGAD).

Their services facilitate seamless access to healthcare resources, enabling better symptom management and improved quality of life for patients. Singlepoint Healthcare operates primarily in the United States, with locations in Ohio, California, Texas, Nevada, and New Jersey. Singlepoint Healthcare generates revenue through a multi-faceted approach that includes direct patient care services, specialty care visits, and clinical research collaborations. The company operates on a fee-for-service model, where patients receive a range of healthcare services such as laboratory testing, infusion treatments, and rehabilitation support, billed directly to insurance providers or patients.

Revenue is derived from these services provided to both individual patients and through partnerships with healthcare networks. Specific pricing plans for individual services are structured based on the complexity and type of care required, reflecting the integrated nature of their offerings. The company emphasizes a patient-centered approach, ensuring that all care services are coordinated, thus enhancing patient outcomes and satisfaction. Singlepoint Healthcare plans to innovate its service offerings to enhance care for patients with chronic inflammatory diseases.

The company is targeting expansion into additional states beyond its current locations in Ohio, California, Texas, Nevada, and New Jersey, with specific regions yet to be announced. The recent acquisition by DFW Capital Partners will likely provide the necessary resources to support these expansion initiatives.